HJ Science Nets HK$1 Billion in Hong Kong IPO Ahead of Debut

MT Newswires Live
06/23

HJ Science (HKG:6132) raised HK$1.02 billion in net proceeds from its initial public offering in Hong Kong, according to a Monday after-market filing with the Hong Kong Exchange.

The clinical-stage biotech company priced its IPO at HK$81.80 per share, issuing 13.6 million shares in total.

The Hong Kong public offering portion of the deal was 2,007.6 times subscribed, with a final allotment of 1.36 million shares.

The international offering was 7 times subscribed, with 12.2 million shares allocated.

Cornerstone investors received 6.2 million shares, representing 45.79% of the IPO shares.

HJ Science is set to debut on the Hong Kong bourse today, June 23.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10